Literature DB >> 28774834

Role of Forkhead Box Class O proteins in cancer progression and metastasis.

Chang Geun Kim1, Hyemin Lee1, Nehal Gupta2, Sharavan Ramachandran2, Itishree Kaushik2, Sangeeta Srivastava3, Sung-Hoon Kim4, Sanjay K Srivastava5.   

Abstract

It is now widely accepted that several gene alterations including transcription factors are critically involved in cancer progression and metastasis. Forkhead Box Class O proteins (FoxOs) including FoxO1/FKHR, FoxO3/FKHRL1, FoxO4/AFX and FoxO6 transcription factors are known to play key roles in proliferation, apoptosis, metastasis, cell metabolism, aging and cancer biology through their phosphorylation, ubiquitination, acetylation and methylation. Though FoxOs are proved to be mainly regulated by upstream phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3 K)/Akt signaling pathway, the role of FoxOs in cancer progression and metastasis still remains unclear so far. Thus, with previous experimental evidences, the present review discussed the role of FoxOs in association with metastasis related molecules including cannabinoid receptor 1 (CNR1), Cdc25A/Cdk2, Src, serum and glucocorticoid inducible kinases (SGKs), CXCR4, E-cadherin, annexin A8 (ANXA8), Zinc finger E-box-binding homeobox 2 (ZEB2), human epidermal growth factor receptor 2 (HER2) and mRNAs such as miR-182, miR-135b, miR-499-5p, miR-1274a, miR-150, miR-34b/c and miR-622, subsequently analyzed the molecular mechanism of some natural compounds targeting FoxOs and finally suggested future research directions in cancer progression and metastasis.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Forkhead Box Class O proteins; Metastasis; Molecules; Natural compounds; mRNAs

Mesh:

Substances:

Year:  2017        PMID: 28774834      PMCID: PMC5794649          DOI: 10.1016/j.semcancer.2017.07.007

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  170 in total

Review 1.  Histone acetylation in gene regulation.

Authors:  Loredana Verdone; Eleonora Agricola; Micaela Caserta; Ernesto Di Mauro
Journal:  Brief Funct Genomic Proteomic       Date:  2006-07-28

2.  miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.

Authors:  Je-Ok Yoo; Seo-Young Kwak; Hyun-Ju An; In-Hwa Bae; Myung-Jin Park; Young-Hoon Han
Journal:  Biochim Biophys Acta       Date:  2016-04-18

Review 3.  Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.

Authors:  Jiri Polivka; Filip Janku
Journal:  Pharmacol Ther       Date:  2013-12-09       Impact factor: 12.310

4.  Casticin induces growth suppression and cell cycle arrest through activation of FOXO3a in hepatocellular carcinoma.

Authors:  Lihua He; Xiaohong Yang; Xiaocheng Cao; Fei Liu; Meifang Quan; Jianguo Cao
Journal:  Oncol Rep       Date:  2012-10-09       Impact factor: 3.906

Review 5.  Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors.

Authors:  Jing Sun; Daohai Zhang; Dong-Hun Bae; Sumit Sahni; Patric Jansson; Ying Zheng; Qian Zhao; Fei Yue; Minhua Zheng; Zaklina Kovacevic; Des R Richardson
Journal:  Carcinogenesis       Date:  2013-05-13       Impact factor: 4.944

6.  The PAX3-FOXO1 fusion protein present in rhabdomyosarcoma interferes with normal FOXO activity and the TGF-β pathway.

Authors:  Michel Schmitt-Ney; Giovanni Camussi
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

7.  MicroRNA-200a suppresses metastatic potential of side population cells in human hepatocellular carcinoma by decreasing ZEB2.

Authors:  Xisheng Yang; Jianlin Wang; Shibin Qu; Hongtao Zhang; Bai Ruan; Yuan Gao; Ben Ma; Xing Wang; Nan Wu; Xiaolei Li; Kefeng Dou; Haimin Li
Journal:  Oncotarget       Date:  2015-04-10

8.  Effusion cytomorphology of small round cell tumors.

Authors:  Katsuhide Ikeda; Koji Tsuta
Journal:  J Cytol       Date:  2016 Apr-Jun       Impact factor: 1.000

9.  Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo.

Authors:  Suresh Kumar Ananda Sadagopan; Nooshin Mohebali; Chung Yeng Looi; Mohadeseh Hasanpourghadi; Ashok Kumar Pandurangan; Aditya Arya; Hamed Karimian; Mohd Rais Mustafa
Journal:  J Exp Clin Cancer Res       Date:  2015-12-08

10.  Src tyrosine kinase signaling antagonizes nuclear localization of FOXO and inhibits its transcription factor activity.

Authors:  Margret H Bülow; Torsten R Bülow; Michael Hoch; Michael J Pankratz; Martin A Jünger
Journal:  Sci Rep       Date:  2014-02-11       Impact factor: 4.379

View more
  36 in total

Review 1.  Src family kinases (SFKs) and cell polarity in the testis.

Authors:  Xiang Xiao; Ya Ni; Chenhuan Yu; Linxi Li; Baiping Mao; Yue Yang; Dongwang Zheng; Bruno Silvestrini; C Yan Cheng
Journal:  Semin Cell Dev Biol       Date:  2017-12-06       Impact factor: 7.727

2.  Atovaquone: An Antiprotozoal Drug Suppresses Primary and Resistant Breast Tumor Growth by Inhibiting HER2/β-Catenin Signaling.

Authors:  Nehal Gupta; Sanjay K Srivastava
Journal:  Mol Cancer Ther       Date:  2019-07-03       Impact factor: 6.261

Review 3.  Emerging role for SRC family kinases in junction dynamics during spermatogenesis.

Authors:  Xiang Xiao; Yue Yang; Baiping Mao; C Yan Cheng; Ya Ni
Journal:  Reproduction       Date:  2019-03       Impact factor: 3.906

Review 4.  MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma: Target Candidates, Functionality and Efficacy in Animal Models and Prognostic Relevance.

Authors:  Ulrich H Weidle; Daniela Schmid; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2020 Jan-Feb       Impact factor: 4.069

5.  β-Ecdysone attenuates cartilage damage in a mouse model of collagenase-induced osteoarthritis via mediating FOXO1/ADAMTS-4/5 signaling axis.

Authors:  Junzhu Han; Jianzhong Guan; Xunbing Zhu
Journal:  Histol Histopathol       Date:  2021-04-20       Impact factor: 2.303

6.  Forkhead box O1 targeting replication factor C subunit 2 expression promotes glioma temozolomide resistance and survival.

Authors:  Xingsheng Qiu; Guifeng Tan; Hao Wen; Lian Lian; Songhua Xiao
Journal:  Ann Transl Med       Date:  2021-04

7.  Atovaquone Suppresses Triple-Negative Breast Tumor Growth by Reducing Immune-Suppressive Cells.

Authors:  Nehal Gupta; Shreyas Gaikwad; Itishree Kaushik; Stephen E Wright; Maciej M Markiewski; Sanjay K Srivastava
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 6.208

Review 8.  PARP inhibitors in gastric cancer: beacon of hope.

Authors:  Yali Wang; Kun Zheng; Yongbiao Huang; Hua Xiong; Jinfang Su; Rui Chen; Yanmei Zou
Journal:  J Exp Clin Cancer Res       Date:  2021-06-24

9.  Atovaquone Suppresses the Growth of Metastatic Triple-Negative Breast Tumors in Lungs and Brain by Inhibiting Integrin/FAK Signaling Axis.

Authors:  Nehal Gupta; Sanjay K Srivastava
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-28

10.  Transcription Factors and Methylation Drive Prognostic miRNA Dysregulation in Hepatocellular Carcinoma.

Authors:  Shijie Qin; Jieyun Xu; Yunmeng Yi; Sizhu Jiang; Ping Jin; Xinyi Xia; Fei Ma
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.